Biocon Limited board approves QIP at ₹387.74 per share, with issue opening on 12 January 2026 and new oncology biosimilars announced.
In the equity market, the 30-share BSE Sensex traded 281.75 points higher at 82,532.68. The 50-share NSE Nifty edged higher by 61.10 points to 25,376.05. She also proposed interventions in six areas, ...
On Wednesday, Biocon stock slipped 0.55 per cent to settle at Rs 364.55 apiece on the BSE.
In an exchange filing, the company said the approval covers Everolimus Tablets for Oral Suspension in 2 mg, 3 mg and 5 mg strengths.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results